Cargando…

Cytokine Gene Polymorphisms in Patients with Chronic Inflammatory Demyelinating Polyneuropathy

Innate and adaptive immune responses exert their role in CIDP pathogenesis through cytokine production. Single-nucleotide polymorphisms (SNPs) may alter cytokine gene expression, with a potential influence on the pathogenesis of autoimmune diseases. However, cytokine gene SNPs have not been assessed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bozovic, Ivo, Perovic, Vladimir, Basta, Ivana, Peric, Stojan, Stevic, Zorica, Popadic, Dusan, Vukovic, Irena, Stojanov, Aleksandar, Milosevic, Emina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453148/ https://www.ncbi.nlm.nih.gov/pubmed/37626843 http://dx.doi.org/10.3390/cells12162033

Ejemplares similares

A longitudinal evaluation of fatigue in chronic inflammatory demyelinating polyneuropathy
por: Gable, Karissa L., et al.
Publicado: (2022)

The influence of the COVID-19 pandemic on patients with chronic inflammatory demyelinating polyradiculoneuropathy
por: Stojanov, Aleksandar, et al.
Publicado: (2021)

Downregulation of LKB1/AMPK Signaling in Blood Mononuclear Cells Is Associated with the Severity of Guillain–Barre Syndrome
por: Paunovic, Verica, et al.
Publicado: (2022)

TNF, IL12B, and IFNG Gene Polymorphisms in Serbian Patients with Psoriasis
por: Popadic, Svetlana, et al.
Publicado: (2015)

Altered cytokine expression in Helicobacter pylori infected patients with bleeding duodenal ulcer
por: Milic, Ljiljana, et al.
Publicado: (2019)

COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis
por: Peric, Stojan, et al.
Publicado: (2022)

Myotonic dystrophy type 1 in the COVID-19 era
por: Ilic Zivojinovic, Jelena, et al.
Publicado: (2023)

Phenotypic and Genetic Heterogeneity of Adult Patients with Hereditary Spastic Paraplegia from Serbia
por: Perić, Stojan, et al.
Publicado: (2022)

Quality of sleep and health-related quality of life among health care professionals treating patients with coronavirus disease-19
por: Stojanov, Jelena, et al.
Publicado: (2020)

Depression with Chronic Inflammatory Demyelinating Polyneuropathy
por: Marwale, Arun, et al.
Publicado: (2018)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak
por: Stojanov, Aleksandar, et al.
Publicado: (2020)

The Impact of the Coronavirus Disease-2019 Pandemic on the Psychological Status and Quality of Life of Myasthenia Gravis Patients
por: Stojanov, Aleksandar, et al.
Publicado: (2020)

A Case of Paraneoplastic Demyelinating Motor Polyneuropathy
por: Mostoufizadeh, Sohrab, et al.
Publicado: (2012)

Tailoring of therapy for chronic inflammatory demyelinating polyneuropathy
por: Rajabally, Yusuf A.
Publicado: (2015)

Challenges in the diagnosis of chronic inflammatory demyelinating polyneuropathy
por: Allen, Jeffrey A., et al.
Publicado: (2018)

The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy
por: Bril, Vera, et al.
Publicado: (2016)

Fatigue in myotonic dystrophy type 1: a seven-year prospective study
por: PERIC, STOJAN, et al.
Publicado: (2019)

Corticosteroids in chronic inflammatory demyelinating polyneuropathy: A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone
por: van Lieverloo, G. G. A., et al.
Publicado: (2018)

Correlations between Electrophysiological Parameters, Lymphocyte Distribution and Cytokine Levels in Patients with Chronic Demyelinating Inflammatory Polyneuropathy
por: Dziadkowiak, Edyta, et al.
Publicado: (2021)

IRIS manifesting as chronic inflammatory demyelinating polyneuropathy in HIV
por: Reghukumar, Aravind, et al.
Publicado: (2014)

Chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus
por: Fatehi, Farzad, et al.
Publicado: (2013)

Chronic Acquired Demyelinating Polyneuropathy following Renal Transplantation
por: Younger, D. S., et al.
Publicado: (2013)

Fibrillary glomerulonephritis combined with chronic inflammatory demyelinating polyneuropathy
por: Sung, Woo Kyung, et al.
Publicado: (2015)

Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy
por: Stettner, Mark, et al.
Publicado: (2015)

Inflammatory demyelinating polyneuropathy after total hip arthroplasty
por: Hess, Shane R., et al.
Publicado: (2018)

Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy
por: Rajabally, Yusuf A, et al.
Publicado: (2020)

Treatment-related fluctuations in subacute inflammatory demyelinating polyneuropathy
por: Min, Young Gi, et al.
Publicado: (2020)

Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy
por: Chaudhary, Umair J., et al.
Publicado: (2020)

Subcutaneous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy
por: Goyal, Namita A., et al.
Publicado: (2021)

Peripheral Nerve Enlargement in Chronic Inflammatory Demyelinating Polyneuropathy
por: Tanitame, Keizo, et al.
Publicado: (2020)

Reversible conduction failure in acute inflammatory demyelinating polyneuropathy
por: Kim, Sooyoung, et al.
Publicado: (2022)

Nerve Ultrasound Score in Chronic Inflammatory Demyelinating Polyneuropathy
por: Tan, Cheng-Yin, et al.
Publicado: (2023)

Nerve Ultrasound Comparison Between Transthyretin Familial Amyloid Polyneuropathy and Chronic Inflammatory Demyelinating Polyneuropathy
por: Du, Kang, et al.
Publicado: (2021)

Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab
por: Cafuir, Lorraine, et al.
Publicado: (2018)

Multifocal visual evoked potentials in chronic inflammatory demyelinating polyneuropathy
por: Graf, Jonas, et al.
Publicado: (2018)

Bilateral optic neuritis related to chronic inflammatory demyelinating polyneuropathy
por: Lin, Kui-Yueh, et al.
Publicado: (2015)

Case Reports of Pembrolizumab-induced Acute Inflammatory Demyelinating Polyneuropathy
por: Manam, Rupesh, et al.
Publicado: (2018)

The Prevalence and Severity of Autonomic Dysfunction in Chronic Inflammatory Demyelinating Polyneuropathy
por: Pasangulapati, Suresh Babu, et al.
Publicado: (2017)

Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
por: Belmokhtar, Chafké, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nvej1uuumb41vmiububeo8q1k4